GPR4 antagonist 1
|
G648341-10mg
|
≥98% |
1197879-16-5 |
10mg
|
¥ 9200.9
|
期货,请咨询 |
阿拉丁 |
GLP-1(32-36)amide
|
G648329-5mg
|
≥98% |
1417302-71-6 |
5mg
|
¥ 2750.9
|
期货,请咨询 |
阿拉丁 |
GLP-1(32-36)amide
|
G648329-10mg
|
≥98% |
1417302-71-6 |
10mg
|
¥ 4650.9
|
期货,请咨询 |
阿拉丁 |
Glycycoumarin
|
G648262-5mg
|
≥99% |
94805-82-0 |
5mg
|
¥ 810.9
|
期货,请咨询 |
阿拉丁 |
Glycycoumarin
|
G648262-25mg
|
≥99% |
94805-82-0 |
25mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
Glycycoumarin
|
G648262-10mg
|
≥99% |
94805-82-0 |
10mg
|
¥ 1350.9
|
期货,请咨询 |
阿拉丁 |
GLUT4-IN-2
|
G648259-5mg
|
|
2454113-83-6 |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
GLUT4-IN-2
|
G648259-50mg
|
|
2454113-83-6 |
50mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
GLUT4-IN-2
|
G648259-25mg
|
|
2454113-83-6 |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
GLUT4-IN-2
|
G648259-10mg
|
|
2454113-83-6 |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
GW438014A
|
G648232-5mg
|
≥99% |
469861-49-2 |
5mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
GW438014A
|
G648232-50mg
|
≥99% |
469861-49-2 |
50mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
GW438014A
|
G648232-25mg
|
≥99% |
469861-49-2 |
25mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
GW438014A
|
G648232-10mg
|
≥99% |
469861-49-2 |
10mg
|
¥ 1600.9
|
期货,请咨询 |
阿拉丁 |
(S,S)-GSK321
|
G648220-5mg
|
≥99% |
1816272-20-4 |
5mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
(S,S)-GSK321
|
G648220-10mg
|
≥99% |
1816272-20-4 |
10mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
Glycoursodeoxycholic Acid-d4
|
G648193-5mg
|
|
2044276-17-5 |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
Glycoursodeoxycholic Acid-d4
|
G648193-1mg
|
|
2044276-17-5 |
1mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
GNE-502
|
G648176-5mg
|
≥99% |
1953134-16-1 |
5mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
GNE-502
|
G648176-1mg
|
≥99% |
1953134-16-1 |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
GNE-502
|
G648176-10mg
|
≥99% |
1953134-16-1 |
10mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
GW779439X
|
G648170-5mg
|
Moligand™, ≥98% |
551919-98-3 |
5mg
|
¥ 1129.9
|
期货,请咨询 |
阿拉丁 |
GW779439X
|
G648170-50mg
|
Moligand™, ≥98% |
551919-98-3 |
50mg
|
¥ 4689.9
|
期货,请咨询 |
阿拉丁 |
GW779439X
|
G648170-25mg
|
Moligand™, ≥98% |
551919-98-3 |
25mg
|
¥ 3179.9
|
期货,请咨询 |
阿拉丁 |